Home » Teva/Active’s MS Pill Shows Promise in Brain Damage
Teva/Active’s MS Pill Shows Promise in Brain Damage
A Phase III trial testing Teva and Active Biotech’s laquinimod for multiple sclerosis (MS) has shown results in treating patients with brain damage due to MS.
Pharma Times
Pharma Times
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May